National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 340614

History of Changes from the VAERS Wayback Machine

First Appeared on 12/8/2009

VAERS ID: 340614
Age:
Gender:Female
Location:Unknown
Vaccinated:2007-10-01
Onset:2007-10-01
Submitted:2009-02-13
Entered:2009-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Alopecia, Amenorrhoea, Skin discolouration, Weight increased

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0901USA01986

Write-up:Information has been received from a doctor of pharmacy concerning her daughter who in October 2007 was vaccinated with the first dose of GARDASIL. In December 2007 the patient received her second dose of GARDASIL and in July 2008 the patient was vaccinated with the third dose of GARDASIL. It was reported by the pharmacist that since her daughter was given the GARDASIL she has not had a menstrual cycle. Her daughter also had dark spots on her hands, has had an increase in weight gain and hair loss since she started the GARDASIL series. The patient had not recovered at the time of the report. Follow up information was received on 16-JAN-2009: the doctor of pharmacy stated that her daughter was not pregnant. She stated her daughter was an otherwise healthy 14 year old. It was reported that the patient was amenorrheic for almost one year. It was reported that the patient was no taking any other concomitant medication. The pharmacist was concerned regarding the possibility of future fertility problems for her daughter in the near future. The doctor of pharmacy had a full medical evaluation scheduled for her daughter in the near future. This is one of several cases from the same source. Additional information has been requested.


Changed on 2/5/2010

VAERS ID: 340614 Before After
Age:(blank) 12.0
Gender:Female
Location:Unknown Illinois
Vaccinated:2007-10-01
Onset:2007-10-01
Submitted:2009-02-13
Entered:2009-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - 1446U / 0 2 UN / UN IM

Administered by: Other Private      Purchased by: Other
Symptoms: Alopecia, Amenorrhoea, Skin discolouration, Weight increased

Life Threatening? No Yes
Died? No
Permanent Disability? No Yes
Recovered? No
ER or Doctor Visit? No Yes
Hospitalized? No Yes, days: (blank) 90     Extended hospital stay? No Yes
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown WBC count, 04/22/09, 12.89; red blood cell count, 04/22/09, 3.15; hemoglobin, 04/22/09, 9.2; hematocrit, 04/22/09, 27.5; mean corpuscular volume, 04/22/09, 87.3; RDW, 04/22/09, 17.1; platelet count, 04/22/09, 338; serum sodium, 04/22/09, 14
CDC 'Split Type': WAES0901USA01986

Write-up:Information has been received from a doctor of pharmacy concerning her daughter who in October 2007 was vaccinated with the first dose of GARDASIL. In December 2007 the patient received her second dose of GARDASIL and in July 2008 the patient was vaccinated with the third dose of GARDASIL. It was reported by the pharmacist that since her daughter was given the GARDASIL she has not had a menstrual cycle. Her daughter also had dark spots on her hands, has had an increase in weight gain and hair loss since she started the GARDASIL series. The patient had not recovered at the time of the report. Follow up information was received on 16-JAN-2009: the doctor of pharmacy stated that her daughter was not pregnant. She stated her daughter was an otherwise healthy 14 year old. It was reported that the patient was amenorrheic for almost one year. It was reported that the patient was no taking any other concomitant medication. The pharmacist was concerned regarding the possibility of future fertility problems for her daughter in the near future. The doctor of pharmacy had a full medical evaluation scheduled for her daughter in the near future. This is one of several cases from the same source. Additional information has been requested. This is in follow-up to report (s) previous submitted on 1/11/2009, 8/7/2009. Information has been received from a doctor of pharmacy concerning her daughter who in October 2007 was vaccinated with the first dose of GARDASIL. In December 2007 the patient received her second dose of GARDASIL and in July 2008 the patient was vaccinated with the third dose of GARDASIL. It was reported by the pharmacist that since her daughter was given the GARDASIL she has not had a menstrual cycle. Her daughter also had dark spots on her hands, has had increase in weight gain and hair loss since she started GARDASIL series. The patient had not recovered at the time of the report. Follow up information was received on 16-JAN-2009, the doctor of pharmacy stated that her daughter was not pregnant. She stated her da


Changed on 7/31/2010

VAERS ID: 340614 Before After
Age:12.0
Gender:Female
Location:Illinois
Vaccinated:2007-10-01
Onset:2007-10-01
Submitted:2009-02-13
Entered:2009-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1446U / 2 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Abdominal distension, Acute hepatic failure, Alanine aminotransferase normal, Alopecia, Amenorrhoea, Arthralgia, Aspartate aminotransferase normal, Autoimmune hepatitis, Blood albumin decreased, Blood bilirubin increased, Blood chloride normal, Blood creatinine decreased, Blood glucose decreased, Blood potassium normal, Blood sodium normal, Blood urea increased, Encephalopathy, Extubation, Haematocrit decreased, Haemoglobin decreased, Jaundice, Leukocytosis, Liver function test abnormal, Liver transplant, Mean cell volume normal, Mental impairment, Oedema peripheral, Platelet count normal, Protein total decreased, Pyrexia, Red blood cell count decreased, Renal failure acute, Respiratory failure, Skin discolouration, Skin papilloma, Tachycardia, Weight increased, White blood cell count increased, Red cell distribution width increased, Blood alkaline phosphatase increased, Dialysis, Endotracheal intubation

Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? Yes, days: 90     Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: WBC count, 04/22/09, 12.89; red blood cell count, 04/22/09, 3.15; hemoglobin, 04/22/09, 9.2; hematocrit, 04/22/09, 27.5; mean corpuscular volume, 04/22/09, 87.3; RDW, 04/22/09, 17.1; platelet count, 04/22/09, 338; serum sodium, 04/22/09, 14
CDC 'Split Type': WAES0901USA01986

Write-up:Information has been received from a doctor of pharmacy concerning her daughter who in October 2007 was vaccinated with the first dose of GARDASIL. In December 2007 the patient received her second dose of GARDASIL and in July 2008 the patient was vaccinated with the third dose of GARDASIL. It was reported by the pharmacist that since her daughter was given the GARDASIL she has not had a menstrual cycle. Her daughter also had dark spots on her hands, has had an increase in weight gain and hair loss since she started the GARDASIL series. The patient had not recovered at the time of the report. Follow up information was received on 16-JAN-2009: the doctor of pharmacy stated that her daughter was not pregnant. She stated her daughter was an otherwise healthy 14 year old. It was reported that the patient was amenorrheic for almost one year. It was reported that the patient was no taking any other concomitant medication. The pharmacist was concerned regarding the possibility of future fertility problems for her daughter in the near future. The doctor of pharmacy had a full medical evaluation scheduled for her daughter in the near future. This is one of several cases from the same source. Additional information has been requested. This is in follow-up to report (s) previous submitted on 1/11/2009, 8/7/2009. Information has been received from a doctor of pharmacy concerning her daughter who in October 2007 was vaccinated with the first dose of GARDASIL. In December 2007 the patient received her second dose of GARDASIL and in July 2008 the patient was vaccinated with the third dose of GARDASIL. It was reported by the pharmacist that since her daughter was given the GARDASIL she has not had a menstrual cycle. Her daughter also had dark spots on her hands, has had increase in weight gain and hair loss since she started GARDASIL series. The patient had not recovered at the time of the report. Follow up information was received on 16-JAN-2009, the doctor of pharmacy stated that her daughter was not pregnant. She stated her da


Changed on 1/4/2011

VAERS ID: 340614 Before After
Age:12.0
Gender:Female
Location:Illinois
Vaccinated:2007-10-01
Onset:2007-10-01
Submitted:2009-02-13
Entered:2009-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1446U / 2 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Abdominal distension, Acute hepatic failure, Alanine aminotransferase normal, Alopecia, Amenorrhoea, Arthralgia, Aspartate aminotransferase normal, Autoimmune hepatitis, Blood albumin decreased, Blood bilirubin increased, Blood chloride normal, Blood creatinine decreased, Blood glucose decreased, Blood potassium normal, Blood sodium normal, Blood urea increased, Encephalopathy, Extubation, Haematocrit decreased, Haemoglobin decreased, Jaundice, Leukocytosis, Liver function test abnormal, Liver transplant, Mean cell volume normal, Mental impairment, Oedema peripheral, Platelet count normal, Protein total decreased, Pyrexia, Red blood cell count decreased, Renal failure acute, Respiratory failure, Skin discolouration, Skin papilloma, Tachycardia, Weight increased, White blood cell count increased, Red cell distribution width increased, Blood alkaline phosphatase increased, Dialysis, Endotracheal intubation

Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? Yes, days: 90     Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: WBC count, 04/22/09, 12.89; red blood cell count, 04/22/09, 3.15; hemoglobin, 04/22/09, 9.2; hematocrit, 04/22/09, 27.5; mean corpuscular volume, 04/22/09, 87.3; RDW, 04/22/09, 17.1; platelet count, 04/22/09, 338; serum sodium, 04/22/09, 14 142; serum potassium, 04/22/09, 4.4; serum chloride, 04/22/09, 109; serum alanine, 04/22/09, 30; serum blood urea, 04/22/09, 50; serum creatinine, 04/22/09, 2.9; serum glucose, 04/22/09, 100; total serum bilirubin, 04/22/09, 2.4; serum albumin, 04/22/09, 2.4; total serum protein, 04/22/09, 4.3; serum aspartate, 04/22/09, 19; serum alkaline, 04/22/09, 164
CDC 'Split Type': WAES0901USA01986

Write-up:Information has been received from a doctor of pharmacy concerning her daughter who in October 2007 was vaccinated with the first dose of GARDASIL. In December 2007 the patient received her second dose of GARDASIL and in July 2008 the patient was vaccinated with the third dose of GARDASIL. It was reported by the pharmacist that since her daughter was given the GARDASIL she has not had a menstrual cycle. Her daughter also had dark spots on her hands, has had an increase in weight gain and hair loss since she started the GARDASIL series. The patient had not recovered at the time of the report. Follow up information was received on 16-JAN-2009: the doctor of pharmacy stated that her daughter was not pregnant. She stated her daughter was an otherwise healthy 14 year old. It was reported that the patient was amenorrheic for almost one year. It was reported that the patient was no taking any other concomitant medication. The pharmacist was concerned regarding the possibility of future fertility problems for her daughter in the near future. The doctor of pharmacy had a full medical evaluation scheduled for her daughter in the near future. This is one of several cases from the same source. Additional information has been requested. This is in follow-up to report (s) previous submitted on 1/11/2009, 8/7/2009. Information has been received from a doctor of pharmacy concerning her daughter who in October 2007 was vaccinated with the first dose of GARDASIL. In December 2007 the patient received her second dose of GARDASIL and in July 2008 the patient was vaccinated with the third dose of GARDASIL. It was reported by the pharmacist that since her daughter was given the GARDASIL she has not had a menstrual cycle. Her daughter also had dark spots on her hands, has had increase in weight gain and hair loss since she started GARDASIL series. The patient had not recovered at the time of the report. Follow up information was received on 16-JAN-2009, the doctor of pharmacy stated that her daughter was not pregnant. She stated her da daughter was an otherwise healthy 14 year old. It was reported that the patient was amenhorrheic for almost, one year. It was reported that the patient was not taking any other concomitant medication. The pharmacist was concerned regarding the possibility of future fertility prolems for her daughter in the near future. The doctor of pharmacy had a full medical evaluation scheduled for her daughter in the near future. This is one of several cases from the same source. On 11-AUG-2007, the patient was vaccinated with the first dose of GARDASIL, intramuscularly. On 20-OCT-2007, the patient was vaccinated with the second dose of GARDASIL intramuscularly. Subsequently, in June 2008 the patient was vaccinated with the third dose of GARDASIL, intramuscularly. Follow up information has been received from a physician and a doctor of pharmacy via medical records, concerning a 14 year old female black patient with no known illness at time of vaccination, no known pre-existing allergies and unremarkable past medical history. The doctor of pharmacy reported that after the first injectiona wart occurred on the patient''s scalp and she became amenorrhaic and lost her hair. After the second and third injection she has skin discoloration, swellling of legs and stomach and weight gain. On 11-AUG-2007, the patient was vaccinated with the first dose of GARDASIL, intramuscularly. On 20-OCT-2007, the patient was vaccinated with the second dose of GARDASIL intramuscularly. Subsequently, in June 2008 the patient was vaccinated with the third dose of GARDASIL intramuscularly. In February 2009, the patient presented to her primary care physician with lower extremity adema and was found to have elevated liver function test. The physician reported that the patient was ultimately diagnosed with Autoimmune hepatitis and was compliant with outpatient treatment. The patient came to the emergency department (inj on 13-MAR-2009 with complaints of joint pai


Changed on 6/14/2014

VAERS ID: 340614 Before After
Age:12.0
Gender:Female
Location:Illinois
Vaccinated:2007-10-01
Onset:2007-10-01
Submitted:2009-02-13
Entered:2009-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1446U / 2 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Abdominal distension, Acute hepatic failure, Alanine aminotransferase normal, Alopecia, Amenorrhoea, Arthralgia, Aspartate aminotransferase normal, Autoimmune hepatitis, Blood albumin decreased, Blood bilirubin increased, Blood chloride normal, Blood creatinine decreased, Blood glucose decreased, Blood potassium normal, Blood sodium normal, Blood urea increased, Encephalopathy, Extubation, Haematocrit decreased, Haemoglobin decreased, Jaundice, Leukocytosis, Liver function test abnormal, Liver transplant, Mean cell volume normal, Mental impairment, Oedema peripheral, Platelet count normal, Protein total decreased, Pyrexia, Red blood cell count decreased, Renal failure acute, Respiratory failure, Skin discolouration, Skin papilloma, Tachycardia, Weight increased, White blood cell count increased, Red cell distribution width increased, Blood alkaline phosphatase increased, Dialysis, Endotracheal intubation

Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? Yes, days: 90     Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: WBC count, 04/22/09, 12.89; red blood cell count, 04/22/09, 3.15; hemoglobin, 04/22/09, 9.2; hematocrit, 04/22/09, 27.5; mean corpuscular volume, 04/22/09, 87.3; RDW, 04/22/09, 17.1; platelet count, 04/22/09, 338; serum sodium, 04/22/09, 142; serum potassium, 04/22/09, 4.4; serum chloride, 04/22/09, 109; serum alanine, 04/22/09, 30; serum blood urea, 04/22/09, 50; serum creatinine, 04/22/09, 2.9; serum glucose, 04/22/09, 100; total serum bilirubin, 04/22/09, 2.4; serum albumin, 04/22/09, 2.4; total serum protein, 04/22/09, 4.3; serum aspartate, 04/22/09, 19; serum alkaline, 04/22/09, 164
CDC 'Split Type': WAES0901USA01986

Write-up:Information has been received from a doctor of pharmacy concerning her daughter who in October 2007 was vaccinated with the first dose of GARDASIL. In December 2007 the patient received her second dose of GARDASIL and in July 2008 the patient was vaccinated with the third dose of GARDASIL. It was reported by the pharmacist that since her daughter was given the GARDASIL she has not had a menstrual cycle. Her daughter also had dark spots on her hands, has had an increase in weight gain and hair loss since she started the GARDASIL series. The patient had not recovered at the time of the report. Follow up information was received on 16-JAN-2009: the doctor of pharmacy stated that her daughter was not pregnant. She stated her daughter was an otherwise healthy 14 year old. It was reported that the patient was amenorrheic for almost one year. It was reported that the patient was no taking any other concomitant medication. The pharmacist was concerned regarding the possibility of future fertility problems for her daughter in the near future. The doctor of pharmacy had a full medical evaluation scheduled for her daughter in the near future. This is one of several cases from the same source. Additional information has been requested. This is in follow-up to report (s) previous submitted on 1/11/2009, 8/7/2009. Information has been received from a doctor of pharmacy concerning her daughter who in October 2007 was vaccinated with the first dose of GARDASIL. In December 2007 the patient received her second dose of GARDASIL and in July 2008 the patient was vaccinated with the third dose of GARDASIL. It was reported by the pharmacist that since her daughter was given the GARDASIL she has not had a menstrual cycle. Her daughter also had dark spots on her hands, has had increase in weight gain and hair loss since she started GARDASIL series. The patient had not recovered at the time of the report. Follow up information was received on 16-JAN-2009, the doctor of pharmacy stated that her daughter was not pregnant. She stated her daughter was an otherwise healthy 14 year old. It was reported that the patient was amenhorrheic for almost, one year. It was reported that the patient was not taking any other concomitant medication. The pharmacist was concerned regarding the possibility of future fertility prolems for her daughter in the near future. The doctor of pharmacy had a full medical evaluation scheduled for her daughter in the near future. This is one of several cases from the same source. On 11-AUG-2007, the patient was vaccinated with the first dose of GARDASIL, intramuscularly. On 20-OCT-2007, the patient was vaccinated with the second dose of GARDASIL intramuscularly. Subsequently, in June 2008 the patient was vaccinated with the third dose of GARDASIL, intramuscularly. Follow up information has been received from a physician and a doctor of pharmacy via medical records, concerning a 14 year old female black patient with no known illness at time of vaccination, no known pre-existing allergies and unremarkable past medical history. The doctor of pharmacy reported that after the first injectiona wart occurred on the patient''s scalp and she became amenorrhaic and lost her hair. After the second and third injection she has skin discoloration, swellling of legs and stomach and weight gain. On 11-AUG-2007, the patient was vaccinated with the first dose of GARDASIL, intramuscularly. On 20-OCT-2007, the patient was vaccinated with the second dose of GARDASIL intramuscularly. Subsequently, in June 2008 the patient was vaccinated with the third dose of GARDASIL intramuscularly. In February 2009, the patient presented to her primary care physician with lower extremity adema and was found to have elevated liver function test. The physician reported that the patient was ultimately diagnosed with Autoimmune hepatitis and was compliant with outpatient treatment. The patient came to the emergency department (inj on 13-MAR-2009 with complaints of joint pai


Changed on 4/14/2017

VAERS ID: 340614 Before After
Age:12.0
Gender:Female
Location:Illinois
Vaccinated:2007-10-01
Onset:2007-10-01
Submitted:2009-02-13
Entered:2009-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1446U / 2 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Abdominal distension, Acute hepatic failure, Alanine aminotransferase normal, Alopecia, Amenorrhoea, Arthralgia, Aspartate aminotransferase normal, Autoimmune hepatitis, Blood albumin decreased, Blood bilirubin increased, Blood chloride normal, Blood creatinine decreased, Blood glucose decreased, Blood potassium normal, Blood sodium normal, Blood urea increased, Encephalopathy, Extubation, Haematocrit decreased, Haemoglobin decreased, Jaundice, Leukocytosis, Liver function test abnormal, Liver transplant, Mean cell volume normal, Mental impairment, Oedema peripheral, Platelet count normal, Protein total decreased, Pyrexia, Red blood cell count decreased, Renal failure acute, Respiratory failure, Skin discolouration, Skin papilloma, Tachycardia, Weight increased, White blood cell count increased, Red cell distribution width increased, Blood alkaline phosphatase increased, Dialysis, Endotracheal intubation

Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? Yes, days: 90     Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: WBC count, 04/22/09, 12.89; red blood cell count, 04/22/09, 3.15; hemoglobin, 04/22/09, 9.2; hematocrit, 04/22/09, 27.5; mean corpuscular volume, 04/22/09, 87.3; RDW, 04/22/09, 17.1; platelet count, 04/22/09, 338; serum sodium, 04/22/09, 142; serum potassium, 04/22/09, 4.4; serum chloride, 04/22/09, 109; serum alanine, 04/22/09, 30; serum blood urea, 04/22/09, 50; serum creatinine, 04/22/09, 2.9; serum glucose, 04/22/09, 100; total serum bilirubin, 04/22/09, 2.4; serum albumin, 04/22/09, 2.4; total serum protein, 04/22/09, 4.3; serum aspartate, 04/22/09, 19; serum alkaline, 04/22/09, 164
CDC 'Split Type': WAES0901USA01986

Write-up:Information has been received from a doctor of pharmacy concerning her daughter who in October 2007 was vaccinated with the first dose of GARDASIL. In December 2007 the patient received her second dose of GARDASIL and in July 2008 the patient was vaccinated with the third dose of GARDASIL. It was reported by the pharmacist that since her daughter was given the GARDASIL she has not had a menstrual cycle. Her daughter also had dark spots on her hands, has had an increase in weight gain and hair loss since she started the GARDASIL series. The patient had not recovered at the time of the report. Follow up information was received on 16-JAN-2009: the doctor of pharmacy stated that her daughter was not pregnant. She stated her daughter was an otherwise healthy 14 year old. It was reported that the patient was amenorrheic for almost one year. It was reported that the patient was no taking any other concomitant medication. The pharmacist was concerned regarding the possibility of future fertility problems for her daughter in the near future. The doctor of pharmacy had a full medical evaluation scheduled for her daughter in the near future. This is one of several cases from the same source. Additional information has been requested. This is in follow-up to report (s) previous submitted on 1/11/2009, 8/7/2009. Information has been received from a doctor of pharmacy concerning her daughter who in October 2007 was vaccinated with the first dose of GARDASIL. In December 2007 the patient received her second dose of GARDASIL and in July 2008 the patient was vaccinated with the third dose of GARDASIL. It was reported by the pharmacist that since her daughter was given the GARDASIL she has not had a menstrual cycle. Her daughter also had dark spots on her hands, has had increase in weight gain and hair loss since she started GARDASIL series. The patient had not recovered at the time of the report. Follow up information was received on 16-JAN-2009, the doctor of pharmacy stated that her daughter was not pregnant. She stated her daughter was an otherwise healthy 14 year old. It was reported that the patient was amenhorrheic for almost, one year. It was reported that the patient was not taking any other concomitant medication. The pharmacist was concerned regarding the possibility of future fertility prolems for her daughter in the near future. The doctor of pharmacy had a full medical evaluation scheduled for her daughter in the near future. This is one of several cases from the same source. On 11-AUG-2007, the patient was vaccinated with the first dose of GARDASIL, intramuscularly. On 20-OCT-2007, the patient was vaccinated with the second dose of GARDASIL intramuscularly. Subsequently, in June 2008 the patient was vaccinated with the third dose of GARDASIL, intramuscularly. Follow up information has been received from a physician and a doctor of pharmacy via medical records, concerning a 14 year old female black patient with no known illness at time of vaccination, no known pre-existing allergies and unremarkable past medical history. The doctor of pharmacy reported that after the first injectiona wart occurred on the patient''s scalp and she became amenorrhaic and lost her hair. After the second and third injection she has skin discoloration, swellling of legs and stomach and weight gain. On 11-AUG-2007, the patient was vaccinated with the first dose of GARDASIL, intramuscularly. On 20-OCT-2007, the patient was vaccinated with the second dose of GARDASIL intramuscularly. Subsequently, in June 2008 the patient was vaccinated with the third dose of GARDASIL intramuscularly. In February 2009, the patient presented to her primary care physician with lower extremity adema and was found to have elevated liver function test. The physician reported that the patient was ultimately diagnosed with Autoimmune hepatitis and was compliant with outpatient treatment. The patient came to the emergency department (inj on 13-MAR-2009 with complaints of joint pai


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=340614&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166